Takeda
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Takeda sits in the top decile of US sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count).
Takeda: 408 sponsored US clinical trials, 49 recruiting.
Takeda sponsors 408 registered US clinical trials on ClinicalTrials.gov, 49 of them currently recruiting, and 284 completed. 174 of these trials are in Phase 3-4 (later-stage) and 209 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy Volunteers, with 16 trials.
Top-decile sponsor footprint
Takeda ranks in the top decile of sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
284 of 340 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
408 total, page 2 of 9
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
NCT06550076
An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver Disease
NCT05899673
A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia
NCT05886491
A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)
NCT05714969
A Study to Assess Maternal and Fetal Outcomes After Taking Prucalopride During Pregnancy
NCT04961840
A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
NCT05020015
A Study of Surgical Interventions in Fistulizing Conditions
NCT04940611
A Study of CDPATH™ to Help Manage and Treat Crohn's Disease
NCT04809363
Post-Marketing Study of Prucalopride Safety In Pregnancy
NCT04869280
A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors
NCT04420884
TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
NCT04129502
A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)
NCT03984097
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326
A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)
NCT03173092
A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
NCT02979522
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer
NCT02716116
A Registry for Participants With Chronic Hypoparathyroidism
NCT01922440
A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease
NCT07250815
A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults
NCT06935266
A Study of TAK-881 and HyQvia in Healthy Adults
NCT06895967
A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults
NCT06793943
A First-In-Human Study of TAK-004 in Healthy Adults
NCT06236009
A Study of TAK-861 for the Treatment of Narcolepsy Type 1
NCT06470828
A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements
NCT06258265
A Study of the Interaction of Other Drugs With TAK-279 in Healthy Adults
NCT06290050
At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill
NCT06150534
A Study to Compare the Relative Bioavailability of Brigatinib When Swallowed as a Solution Versus When Swallowed as a Tablet in Healthy Adults
NCT06132867
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period
NCT06108544
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment
NCT06088043
A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases
NCT05755035
A Study of TAK-279 in Adults With or Without Kidney Problems
NCT05992155
A Study of TAK-279 in Adults With or Without Liver Damage
NCT05976321
A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults
NCT05995249
A Study of Maribavir Pediatric Formulation in Healthy Adult Participants
NCT05918822
A Study of TAK-227 in Healthy Adults
NCT05818956
A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery
NCT05814016
A Study to Describe Mothers' and Babies' Outcomes After Exposure to HyQvia During Pregnancy
NCT05803200
A Study to Determine the Effect Food Has on TAK-721 (Budesonide Oral Suspension) in the Body of Healthy Adults
NCT06268301
A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4
NCT07052682
A Study of TAK-861 in Participants With Narcolepsy Type 1
NCT05687903
A Study of TAK-861 in Participants With Narcolepsy Type 2
NCT05687916
A Study of TAK-341 in Treatment of Multiple System Atrophy
NCT05526391
A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experience
NCT05602818
Virtual Celiac Symptoms Study in Adults and Teenagers
NCT05309330
A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy
NCT05174221
A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet
NCT05353985
Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet
NCT04530123
A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT05363358
Maribavir Food-Effect Study in Healthy Adults Participants
NCT05382104
First-in-Human Study of TAK-280 in Participants With Solid Tumors
NCT05220098
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 119 |
| Phase 2 | 90 |
| Phase 3 | 148 |
| Phase 4 | 26 |
What is open in the Takeda pipeline
49 recruiting of 408 indexed (12% open); 284 completed (70%).
Phase mix: 174 late (III/IV) vs 209 early (I/II) (balanced across stages).
Top condition: Healthy Volunteers (16 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Takeda: open-pipeline peers nationwide
Peers matched on 408 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
Takeda sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 408 trials (± recruiting share)
- University of Kansas Medical Center · 408 trials · 23% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
- University of Nebraska · 407 trials · 13% recruiting
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Arcus Biosciences · 12% recruiting · 25 trials
- Ardelyx · 12% recruiting · 25 trials
- Kyowa Kirin Co. · 12% recruiting · 25 trials
- East Carolina University · 12% recruiting · 58 trials
Related
What to do with this Takeda page
408 registered trials is a research-attention snapshot, not an endorsement of Takeda or any single study.
- 49 of Takeda's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy Volunteers is the condition Takeda studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy Volunteers trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Takeda pipeline card: 408 registered trials from official public datasets.Report a data error.